BA
Biswajit Anath Paul
About Biswajit Anath Paul
Data last updated:
Biswajit Anath Paul has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Ciron Drugs And Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Ciron Drugs And Pharmaceuticals Private Limited at ₹305 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ciron Drugs And Pharmaceuticals Private Limited U24246MH1990PTC056735 | Director | 12 May 2021 | 1990 | ₹305 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Biswajit Anath Paul
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biswajit Anath Paul
Biswajit Anath Paul has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Ciron Drugs And Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Ciron Drugs And Pharmaceuticals Private Limited at ₹305 Cr (FY 2024).
Biswajit Anath Paul is associated with 1 company as Director, including Ciron Drugs And Pharmaceuticals Private Limited (₹305 Cr).
Biswajit Anath Paul has expertise in General Business.
Biswajit Anath Paul has 5 years in corporate governance.
By reported revenue, the largest current company of Biswajit Anath Paul is Ciron Drugs And Pharmaceuticals Private Limited, with revenue of ₹305 Cr (FY 2024).
Biswajit Anath Paul currently holds positions at 1 company: Ciron Drugs And Pharmaceuticals Private Limited (₹305 Cr).